Skip to main content
HCSGHealthcare Services Group, Inc.Sell5.6·$23.58+4.11%
HCSG · Why this verdict

Why Healthcare Services Group (HCSG) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.6/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Healthcare Services Group trades just 2.2% below analyst consensus, delivering an unfavorable 0.4-to-1 reward-to-risk profile despite three consecutive earnings beats with large positive surprises and free cash flow conversion at 139% of net income; elevated leverage and near-exhausted price upside make adding exposure inadvisable at current levels.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

The company has delivered three consecutive quarterly earnings beats with large positive surprises — 72%, 96%, and 197% in the most recent three quarters — signaling a period of consistent delivery against analyst estimates after a severe miss in the oldest quarter reviewed.

Stable
Earnings
Expectation
EPS beats continue for at least 2 more consecutive quarters with positive surprises above 20%, sustaining the recent delivery track record.

CounterThe oldest quarter in the reviewed period was a severe miss at -315% surprise, demonstrating that earnings can be highly volatile; the elevated RSI of 75 suggests the market may have already priced in expectations of continued beats.

Free cash flow conversion stands at 139% of net income, indicating the business generates significantly more cash than reported earnings — a sign of conservative accounting and strong working capital dynamics.

Stable
Quality breakdown
Expectation
FCF/NI ratio remains above 100% over the next 4 quarters, confirming the conversion quality is structural rather than episodic.

CounterThe absence of an identifiable competitive moat limits pricing power, which may eventually pressure the operating margins that underpin the high cash conversion ratio.

With the stock just 2.2% below the analyst consensus target and a 0.4-to-1 reward-to-risk ratio, the current setup offers minimal potential gain against 12.9% of implied downside — a configuration that does not compensate for the risk of holding.

Stable
Price targets
Expectation
Setup improves as either the price retreats to create better asymmetry, or analysts raise consensus targets to deliver more than 15% of upside headroom.

CounterNear-term momentum remains strong — RSI at 75, volume accumulation, and the stock holding above its 200-day moving average — which could carry the price beyond current consensus targets before any meaningful pullback.

A debt-to-equity ratio of 2.9 represents elevated leverage that constrains financial flexibility and reduces the business's ability to absorb earnings shortfalls without balance sheet stress.

Stable
Bear case
Expectation
Debt-to-equity declines below 2.0 over the next 4 quarters as earnings growth enables deleveraging.

CounterA Piotroski F-score of 7 out of 9 indicates financial statement health across multiple accounting dimensions, suggesting the leverage is being managed within the firm's capacity to service it.

Per-dimension breakdown

Value

6.1/10data confidence 100%
ComponentSub-score
P/E5.3
P/S9.8
EV/EBITDA0.0
Fwd P/E6.5
PEG10.0
Analyst target4.0
  • Forward P/E: 19.6x
  • PEG: 0.32

Quality

4.8/10data confidence 100%
ComponentSub-score
ROE4.4
ROA3.0
Gross margin0.0
Op margin2.9
Net margin1.8
Current ratio9.9
FCF quality9.6
Moat4.2
Piotroski F7.8
  • Excellent cash conversion: 139% FCF/NI
  • No competitive moat
  • Strong Piotroski F-Score: 7/9

Growth

6.7/10data confidence 67%
ComponentSub-score
Rev growth3.4
EPS growth10.0

Momentum

7.5/10data confidence 100%
ComponentSub-score
RSI3.8
MACD10.0
OBV10.0
MA position9.0
Volume4.9
  • Overbought (RSI 85)
  • Volume accumulation (rising OBV)
  • Above 200-day MA

Sentiment

5.5/10data confidence 100%
ComponentSub-score
Analyst rating5.0
Price target6.6
erm sentiment5.0

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.1
  • No net insider activity — $0 (0.000% of mkt cap)

Peer rank

4.2/10data confidence 80%
ComponentSub-score
value rank4.9
quality rank4.3
growth rank2.6

Technical

3.2/10data confidence 100%
ComponentSub-score
bollinger0.2
support resistance0.2
52w position9.3

Risk (lower is worse)

4.9/10data confidence 100%
ComponentSub-score
short interest8.0
days to cover6.9
volatility5.9
put call0.0
implied vol3.4
beta8.0
debt equity2.1
  • Elevated put/call: 15.00

Catalyst

6.3/10data confidence 100%
ComponentSub-score
erm5.0
earnings history6.7
earnings timing5.0
surprise avg8.6
  • Strong earnings: 3B/1M

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (7)
  • MOMENTUM:7.5>=5.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:28d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-0.2=NEGATIVE
Warning (0)

none

Reward-to-Risk
-0.22
Upside
-3.3%
Downside
15.0%
Sizing output
AVOID

SetupUNKNOWN No clear chart pattern; technical signals are mixed

EdgeCATALYST Earnings in 28d with 3/4 beat streak

SuitabilityAGGRESSIVE MCap $1.6B<$5B

Investment implication

The F-path SELL output reflects an overall score of 4.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Momentum at 7.5) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.2=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.22 — supplementary context, not the trigger for this path.

The strongest dimensions are Momentum at 7.5, Growth at 6.7, and Catalyst at 6.3; the weakest are Technical at 3.2, Peer rank at 4.2, and Quality at 4.8. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of -0.22 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1The company has delivered three consecutive quarterly earnings beats with large positive surprises — 72%, 96%, and 197% in the most recent three quarters — signaling a period of consistent delivery against analyst estimates after a severe miss in the oldest quarter reviewed.

    Trip ifEPS surprise falls below 0% for 2 consecutive quarters.

  • P2Free cash flow conversion stands at 139% of net income, indicating the business generates significantly more cash than reported earnings — a sign of conservative accounting and strong working capital dynamics.

    Trip ifFCF/NI ratio falls below 100% for 2 consecutive reporting quarters.

  • P3With the stock just 2.2% below the analyst consensus target and a 0.4-to-1 reward-to-risk ratio, the current setup offers minimal potential gain against 12.9% of implied downside — a configuration that does not compensate for the risk of holding.

    Trip ifAnalyst consensus price target is raised such that upside to the new target exceeds 15% from the prevailing price.

  • P4A debt-to-equity ratio of 2.9 represents elevated leverage that constrains financial flexibility and reduces the business's ability to absorb earnings shortfalls without balance sheet stress.

    Trip ifDebt-to-equity ratio falls below 2.0 over 2 consecutive reporting periods.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks HCSG Why this verdict